Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Journal of Medicinal Chemistry|January 23, 2018
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small MoleculeChiara Marchetti, Katherine G Zyner, Stephan A Ohnmacht, et al.
Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.
Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.
Diabetes Technology & Therapeutics|May 25, 2023
Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin DeliveryHeba Alwan, Julia Ware, Charlotte K Boughton, et al.
Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.
Journal of Diabetes Science and Technology|December 21, 2022
Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 DiabetesMustafa Fattah, Charlotte K Boughton, Julia Ware, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
Nature Communications|April 2, 2021
Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humansAngelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, et al.
Pageof 15